BridgeBio Oncology Therapeutics Balance Sheet (2023-2026) | BBOT

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter) 1.84M1.81M1.79M30.85M0.96M0.66M408.74M373.69M52.66M54.06M
Short-term Investments (Quarter) 124.78M59.54M51.77M199.62M171.65M
Cash & Current Investments (Quarter) 1.84M1.81M1.79M155.63M0.96M0.66M468.29M425.46M252.28M225.71M
Receivables (Quarter) 0.08M0.39M0.15M0.66M
Securities (Quarter) 5.88M44.46M336.23M290.07M
Prepaid Assets (Quarter) 0.02M0.01M0.01M2.98M0.06M0.15M7.50M6.55M14.08M16.01M
Current Assets (Quarter) 2.11M2.08M2.04M158.69M1.24M0.88M476.01M432.40M266.50M242.38M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 0.49M0.83M0.96M0.94M0.88M
Long-Term Investments (Quarter) 6.00187.65M190.20M634.0031.00196.51M136.62M118.42M
Long-Term Deferred Tax (Quarter) 0.33M
Other Non-Current Assets (Quarter) 0.21M0.13M5.38M12.57M0.13M12.79M
Non-Current Assets (Quarter) 185.42M187.80M190.29M5.61M194.44M196.51M8.78M15.98M151.14M134.33M
Assets (Quarter) 0.33M187.53M189.87M192.33M164.30M195.68M197.39M484.79M448.38M417.65M376.71M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 0.01M3.07M2.52M3.65M1.37M12.09M6.73M
Notes Payables (Quarter) 0.07M0.48M0.09M0.11M0.69M0.53M0.72M
Payables (Quarter) 0.07M0.01M3.56M0.09M2.63M4.34M1.91M12.81M6.73M
Accumulated Expenses (Quarter) 0.01M0.02M0.08M0.13M3.82M1.78M4.49M5.75M2.02M4.39M
Other Accumulated Expenses (Quarter) 0.17M0.18M0.24M0.55M0.20M
Current Leases (Quarter) 0.51M0.52M0.54M0.55M
Total Current Liabilities (Quarter) 0.40M0.02M0.08M0.13M19.58M1.87M2.63M35.71M35.04M43.26M51.63M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter) 5.52M5.52M5.52M5.52M5.52M5.52M
Preferred Stock Liabilities (Quarter) 185.21M187.65M190.20M192.45M194.44M196.51M
Operating Leases (Quarter) 2.38M2.24M2.11M1.96M
Total Liabilities (Quarter) 0.40M5.54M5.60M5.65M19.58M7.39M8.15M38.09M37.28M45.37M53.59M
Shareholder's Equity
Common Equity (Quarter) -115.64M-128.87M-143.44M-159.21M-178.64M-200.03M-227.73M446.70M411.10M372.28M323.11M
Liabilities and Shareholders Equity (Quarter) 0.33M187.53M189.87M192.33M164.30M195.68M197.39M484.79M448.38M417.65M376.71M
Retained Earnings (Quarter) 0.02M-3.22M-3.37M-3.52M43.54M-6.15M-7.27M0.04M-356.57M-0.98M779.19M
Preferred Shares (Quarter) 323.36M
Treasury Shares (Quarter) 0.28M